MyoKardia, Inc.
NASDAQ: MYOK
$224.91
+$0.00 (+0.0%)
Closing price November 17, 2020
Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and Shopify.
2 years ago
Last Updated: 2 years ago
MyoKardia shares hit an all-time high early on Monday after it was announced that Bristol-Myers Squibb would be acquiring the company.
2 years ago
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten.
2 years ago